Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.47 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | BMP1 | P13497 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14998213 | 0.84 | GLP1R (0.57) | GLP1R | |
| SCHEMBL13267758 | 0.84 | GLP1R (0.44) | GLP1RGLO1PTGS1GSTK1 | |
| SCHEMBL172853 | 0.83 | GLO1 (0.49) | GLP1RGLO1PTGS1GSTK1BMP1 | |
| SCHEMBL16093420 | 0.81 | GLP1R (0.54) | GLP1RSELP | |
| SCHEMBL26739923 | 0.78 | GLP1R (0.50) | GLP1RGLO1 | |
| SCHEMBL13165209 | 0.78 | GLP1R (0.61) | GLP1RSELP | |
| SCHEMBL91017 | 0.78 | GLP1R (0.61) | GLP1RSELP | |
| SCHEMBL15002730 | 0.78 | GLP1R (0.61) | GLP1RSELP | |
| SCHEMBL13973930 | 0.78 | GLP1R (0.61) | GLP1RSELP | |
| SCHEMBL73399 | 0.78 | GLP1R (0.61) | GLP1RSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058932-A1 | ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION | MAX PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058932-A1 | ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION | VIP, FIBP, MMP7 | GLP1R 144/4885GLO1 2485/4885PTGS1 1350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.